Seamus Gorman, chief operating officer of Hibergene

Dublin-based medtech company Hibergene, which is working on a rapid diagnostic test for Covid-19, has secured funding of €1 million from the European (...)

HiberGene chief executive Brendan Farrell said the company was halfway through its latest fundraising round.

Irish firm HiberGene Diagnostics has unveiled a new combination test for meningococcal and pneumococcal meningitis that can give accurate results in a(...)

Brendan Farrell, chief executive of Hibergene Diagnostics: company is “grateful to our investors for providing the funding which will enable Hibergene to significantly expand both its range of diagnostic products and its global reach”. Photograph: Peter Houlihan

Diagnostics group Hibergene has raised €6.7 million in a funding round led by Cantor Fitzgerald. The company specialises in developing tests for inf(...)

The new test was developed at Belfast’s Royal Victoria Hospital with 	funding from the UK’s Meningitis Research Foundation and Northern Ireland’s NHS Trust, and licensed exclusively to HiberGene

Dominic Coyle A Dublin company has won EU approval for a new test that allows doctors to confirm the potentially fatal bacterial meningitis (...)